The anti-GITR antibody in tumor-bearing mice can break immunological self-tolerance and evoke a potent anti-tumor immune response with an increase in IFN-γ-producing CD8+ and CD4+ T cells [80,81]. This evidence concerns the gene CD8A and neoplasm.